Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative analgesia with sufentanil vs tegileridine in laparoscopic cholecystectomy
ChiCTR2500112585Phase 4Not yet recruiting
- Sponsor
- Puyang Oilfield General Hospital
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Cholecystolithiasis and cholecystitis comparing Sufentanil PCA arm with Tegileridine PCA arm (2 arms). Primary endpoint: Incidence of moderate to severe pain at 24 hours postoperatively. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
sufentaniltegileridine
03
Conditions
Cholecystolithiasischolecystitis
Beyond the preview
Go deeper on ChiCTR2500112585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112585.